Negative Pressure Wound Therapy

Negative Pressure Wound Therapy (NPWT), also known as vacuum-assisted closure (VAC), is a sophisticated wound management modality that applies controlled sub-atmospheric pressure to the wound bed through a sealed occlusive dressing connected to a vacuum pump. This therapy is designed to promote healing in acute, chronic, and complex wounds by creating a localized negative pressure environment that enhances blood flow, reduces edema, stimulates granulation tissue formation, decreases bacterial colonization, and facilitates wound contraction. In veterinary surgery, NPWT is utilized for a variety of wounds including traumatic skin loss, degloving injuries, infected surgical sites, fasciotomy wounds, and open fractures with soft tissue compromise. The system typically consists of a polyurethane or polyvinyl alcohol foam dressing, an occlusive adhesive drape, a collection canister, and a vacuum pump that delivers continuous or intermittent negative pressure, usually ranging from -80 to -125 mmHg in small animals. The therapy is applied for several days to weeks, with dressing changes every 48 to 72 hours, and is often used as a bridge to definitive closure or as a primary treatment for wounds healing by second intention. NPWT has revolutionized wound care in both human and veterinary medicine by providing a closed, moist, and controlled environment that accelerates the healing cascade, reduces the need for frequent painful dressing changes, and improves overall patient outcomes.

Negative Pressure Wound Therapy is not a disease but a therapeutic intervention; however, the conditions it treats have diverse etiologies. The primary indications for NPWT in veterinary patients include traumatic wounds such as degloving injuries (often from motor vehicle accidents or limb entrapment), bite wounds with extensive tissue necrosis, avulsion injuries, and shearing injuries of the distal extremities. Iatrogenic causes include surgical wound dehiscence, infected surgical incisions, and skin graft or flap failure. Infectious etiologies, such as necrotizing fasciitis or severe abscessation, may also necessitate NPWT to manage the wound bed after surgical debridement. Additionally, NPWT is used for chronic non-healing wounds associated with underlying metabolic diseases (e.g., diabetes mellitus, hyperadrenocorticism), vascular compromise, or radiation injury. In some cases, NPWT is applied to open fractures with soft tissue loss to prepare the wound for delayed closure or grafting. The therapy is also employed in the management of fasciotomy wounds in patients with compartment syndrome, and in the treatment of pressure sores or decubital ulcers in recumbent patients. The underlying cause of the wound dictates the need for NPWT, and it is essential to address the primary etiology (e.g., infection, foreign body, neoplasia) in conjunction with NPWT to achieve successful healing.

The use of NPWT in veterinary medicine has increased significantly over the past two decades, paralleling its widespread adoption in human surgery. Epidemiological data specific to veterinary NPWT are limited, but the therapy is most commonly applied in dogs and cats, with dogs being the predominant species due to their higher incidence of traumatic wounds. In dogs, breeds with a high activity level or those used for working purposes (e.g., hunting, agility, police work) are more prone to degloving and shearing injuries, making them frequent candidates for NPWT. There is no clear breed or sex predisposition for NPWT itself, but the underlying wound types may have breed associations; for example, sight hounds may be more susceptible to distal limb injuries due to their racing activity. Age distribution is bimodal: young, active animals (1-3 years) often present with acute trauma, while older animals (8+ years) may have chronic wounds related to neoplasia or metabolic disease. Feline patients are less commonly treated with NPWT, but the therapy is effective in cats with severe bite wounds or degloving injuries. The incidence of NPWT use in veterinary referral centers is rising, with studies reporting successful outcomes in 80-90% of cases. However, the lack of standardized protocols and equipment specifically designed for veterinary patients has limited its widespread use, and many cases are managed with human NPWT devices adapted for animal use.

The pathophysiology of wound healing under NPWT is complex and involves multiple mechanisms that synergistically promote tissue repair. The application of negative pressure to the wound bed induces mechanical deformation of the tissue, leading to macro- and micro-deformation of the wound edges. Macro-deformation results in wound contraction, reducing the wound surface area and bringing the wound edges closer together. Micro-deformation at the cellular level stretches the cytoskeleton of fibroblasts and endothelial cells, triggering intracellular signaling pathways that promote cell proliferation, migration, and differentiation. This mechanical strain upregulates the expression of growth factors such as vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and platelet-derived growth factor (PDGF), which stimulate angiogenesis and granulation tissue formation. The negative pressure also removes excess interstitial fluid and edema from the wound bed, reducing tissue pressure and improving local microcirculation. This enhanced blood flow delivers oxygen and nutrients to the wound, while removing metabolic waste products. Additionally, the occlusive dressing creates a moist, closed environment that prevents bacterial contamination and reduces the risk of nosocomial infection. The negative pressure also alters the bacterial load by mechanically removing bacteria and biofilm from the wound surface, and by creating a hypoxic environment that may inhibit the growth of certain pathogens. Furthermore, NPWT has been shown to modulate the inflammatory response, reducing pro-inflammatory cytokines and promoting a more balanced healing environment. The combination of these effects accelerates the formation of healthy granulation tissue, reduces wound chronicity, and prepares the wound bed for surgical closure or grafting.

Several factors predispose veterinary patients to wounds that may require NPWT. Intrinsic factors include age, with very young and geriatric animals having reduced healing capacity; body condition, as obese animals have compromised vascularity and increased tension on wound edges; and nutritional status, with malnutrition impairing collagen synthesis and immune function. Metabolic diseases such as diabetes mellitus, hyperadrenocorticism, and hypothyroidism can delay wound healing and increase infection risk. Immunosuppression, whether from disease or medication (e.g., corticosteroids, chemotherapy), predisposes to wound infection and dehiscence. Extrinsic factors include the nature and severity of the trauma, with high-energy injuries (e.g., motor vehicle accidents, gunshot wounds) causing extensive tissue devitalization and contamination. Poor wound management, such as delayed debridement or inadequate lavage, can lead to infection and wound chronicity. Environmental factors, such as exposure to dirt, feces, or foreign bodies, increase the risk of infection. Surgical factors, including excessive tension on sutures, poor aseptic technique, or compromised blood supply to the surgical site, can lead to wound breakdown. Additionally, patient factors such as excessive activity or self-trauma (licking, chewing) can disrupt wound healing. In the context of NPWT, the presence of these predisposing factors often necessitates the use of this advanced therapy to overcome the impaired healing environment.

Clinical signs associated with wounds that may benefit from NPWT vary depending on the underlying cause and severity. Acute traumatic wounds often present with visible tissue loss, hemorrhage, and contamination. Degloving injuries, commonly seen on the distal limbs, exhibit extensive skin and soft tissue avulsion, exposing underlying tendons, bones, and joints. Shearing injuries may present with abrasions and full-thickness skin loss, often with associated orthopedic injuries such as fractures or joint luxations. Bite wounds may appear as puncture wounds initially but can rapidly progress to extensive necrosis and abscessation due to deep bacterial inoculation. Chronic wounds, such as pressure sores, present as non-healing ulcers with necrotic tissue, exudate, and possible sinus tracts. Infected surgical wounds show signs of dehiscence, purulent discharge, erythema, and local heat. Systemic signs may include fever, lethargy, and anorexia if infection is severe. Pain is a common feature, and patients may exhibit lameness or reluctance to bear weight on the affected limb. In cases of necrotizing fasciitis, there is rapid progression of tissue necrosis, severe pain, and systemic toxicity. The presence of a wound with these characteristics, especially when it is large, contaminated, or failing to heal, should prompt consideration of NPWT as part of the treatment plan.

When evaluating a wound for potential NPWT, it is essential to consider differential diagnoses that may mimic or complicate the wound. Differential diagnoses include: 1) Simple lacerations or abrasions that may heal with conventional management; 2) Abscesses, which require drainage and appropriate antibiotic therapy; 3) Foreign body reactions, which necessitate removal of the inciting material; 4) Neoplasia, such as soft tissue sarcomas or mast cell tumors, which may present as non-healing wounds and require biopsy; 5) Pyoderma or deep bacterial infections, which may respond to systemic antibiotics and topical therapy; 6) Osteomyelitis, which may be associated with underlying bone infection and require imaging and long-term antibiotics; 7) Burns, which have a distinct pathophysiology and may require specialized care; 8) Frostbite, which can cause tissue necrosis and may mimic traumatic wounds; 9) Autoimmune diseases, such as pemphigus or vasculitis, which can cause skin ulceration; 10) Radiation injury, which can lead to chronic non-healing wounds. Each differential diagnosis has unique clinical features: for example, neoplasia may present with a proliferative mass, while osteomyelitis may show bone changes on radiographs. Definitive diagnosis often requires cytology, histopathology, culture, and advanced imaging. NPWT is not a substitute for addressing the underlying cause, and it is crucial to rule out these conditions before initiating therapy.

The diagnostic algorithm for a wound that may benefit from NPWT begins with a thorough history and physical examination. The clinician should assess the wound's size, depth, location, and degree of contamination. The presence of foreign material, necrotic tissue, or purulent discharge should be noted. A complete blood count and serum biochemistry profile are recommended to evaluate for systemic infection, metabolic disease, or organ dysfunction. Wound cultures should be obtained from deep tissue samples, not superficial swabs, to guide antibiotic therapy. Imaging studies, such as radiography, are essential to rule out underlying fractures, foreign bodies, or osteomyelitis. Ultrasonography may be useful to assess soft tissue involvement and fluid accumulation. In complex cases, computed tomography (CT) or magnetic resonance imaging (MRI) may be indicated to delineate the extent of tissue damage and plan surgical debridement. If neoplasia is suspected, fine-needle aspiration or biopsy should be performed. Once the wound is characterized and the underlying cause is addressed, the decision to use NPWT is made based on wound characteristics such as size, depth, and healing potential. The wound is then surgically debrided and lavaged, and NPWT is applied. Serial wound assessments, including measurement of wound dimensions and evaluation of granulation tissue formation, are performed during NPWT to monitor progress and determine when to transition to closure or continued second-intention healing.

Laboratory findings in patients undergoing NPWT are not specific to the therapy but reflect the underlying wound and any systemic disease. Hematology may reveal leukocytosis with a left shift in cases of bacterial infection, or leukopenia in severe sepsis. Anemia may be present due to blood loss or chronic inflammation. Serum biochemistry may show hypoalbuminemia due to protein loss through the wound or malnutrition, which can impair healing. Elevated liver enzymes or creatinine may indicate organ dysfunction that could affect drug metabolism and wound healing. Coagulation parameters (PT, aPTT, platelet count) should be assessed if there is significant bleeding or if surgical intervention is planned. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in infectious or inflammatory conditions and can be monitored to assess response to therapy. Wound culture and sensitivity are critical to identify the causative organisms and guide antimicrobial therapy. Synovial fluid analysis may be performed if a joint is involved, revealing increased nucleated cell counts and protein concentration in septic arthritis. Blood gas analysis may be indicated in critically ill patients to assess acid-base status and oxygenation. Overall, laboratory findings help to identify and manage concurrent diseases that could affect wound healing and the success of NPWT.

Imaging plays a crucial role in the evaluation of wounds that may require NPWT. Radiography is the initial imaging modality and is essential to identify underlying fractures, foreign bodies, or osteomyelitis. In degloving injuries, radiographs can reveal fractures, joint luxations, or gas in the soft tissues, indicating infection. Ultrasonography is useful to assess soft tissue structures, such as tendons and muscles, and to detect fluid pockets or abscesses that may require drainage. Color Doppler ultrasound can evaluate blood flow to the wound area, which is important for assessing viability. Computed tomography (CT) provides detailed three-dimensional information about bone and soft tissue, and is particularly valuable in complex wounds with suspected foreign bodies or deep infection. CT angiography can assess vascular integrity and perfusion. Magnetic resonance imaging (MRI) offers superior soft tissue contrast and is useful for evaluating muscle viability, tendon injuries, and the extent of inflammation or necrosis. In cases of suspected osteomyelitis, MRI can detect bone marrow edema and cortical destruction. Nuclear scintigraphy may be used to assess bone viability and infection. During NPWT, imaging is not routinely performed, but radiographs may be repeated to monitor fracture healing or to detect complications such as implant failure. Advanced imaging is reserved for complex cases where surgical planning is required.

Cytology and histopathology are important diagnostic tools in the management of wounds considered for NPWT. Cytological examination of wound exudate or fine-needle aspirates can identify inflammatory cells, bacteria, and neoplastic cells. Gram staining can provide preliminary information about bacterial type. Histopathology of tissue biopsies is essential to diagnose underlying neoplasia, vasculitis, or other inflammatory conditions. In wounds with suspected infection, tissue biopsy for culture and histopathology is recommended, as superficial swabs may not reflect deep tissue infection. Histopathological features of infected wounds include necrosis, neutrophilic infiltration, and bacterial colonies. In chronic wounds, there may be fibrosis, granulation tissue, and evidence of biofilm formation. If neoplasia is suspected, histopathology can determine the tumor type, grade, and surgical margins, which is critical for treatment planning. Special stains, such as Masson's trichrome for collagen or Gram stain for bacteria, may be used. In the context of NPWT, histopathology is not routinely performed on the wound bed, but biopsies may be taken to assess the quality of granulation tissue or to rule out persistent infection. Cytology and histopathology are invaluable for guiding therapy and ensuring that NPWT is applied to a wound that has the potential to heal.

The treatment of wounds with NPWT involves a comprehensive approach that includes patient stabilization, wound preparation, application of NPWT, and subsequent wound closure or management. Initial treatment focuses on addressing any life-threatening conditions, such as hemorrhage, shock, or systemic infection. The wound is then surgically debrided to remove all necrotic tissue, foreign material, and contaminants. Copious lavage with sterile saline or a dilute antiseptic solution (e.g., 0.05% chlorhexidine) is performed to reduce bacterial load. After debridement, NPWT is applied. The wound bed is covered with a sterile foam dressing (polyurethane or polyvinyl alcohol) cut to fit the wound dimensions. The foam is placed into the wound, and an occlusive adhesive drape is applied over the foam, ensuring an airtight seal. A suction tube is inserted into the foam and connected to a vacuum pump. Negative pressure is typically set at -80 to -125 mmHg, either continuously or intermittently (e.g., 5 minutes on, 2 minutes off). The dressing is changed every 48 to 72 hours, or more frequently if there is heavy exudate or infection. During dressing changes, the wound is reassessed, and further debridement is performed if necessary. NPWT is continued until the wound bed is covered with healthy granulation tissue, which usually takes 1 to 3 weeks. At that point, the wound can be closed surgically via primary closure, skin grafts, or flaps, or it may be allowed to heal by second intention. In some cases, NPWT is used postoperatively to support skin grafts or flaps by reducing shear forces and improving graft adherence. Adjunctive treatments include systemic antibiotics based on culture and sensitivity, analgesics for pain management, and nutritional support to optimize healing. Physical therapy and bandaging may be used after NPWT to protect the wound and maintain joint mobility.

The prognosis for wounds treated with NPWT is generally favorable, with reported success rates of 80-90% in veterinary studies. The therapy significantly accelerates granulation tissue formation, reduces wound size, and decreases the time to wound closure compared to conventional dressings. Short-term prognosis is excellent for most patients, with most wounds achieving a healthy granulation bed within 1-3 weeks. Medium-term prognosis depends on the underlying cause and the ability to achieve definitive closure. Wounds that are closed surgically after NPWT have a good prognosis, with graft and flap survival rates reported at 80-100%. Long-term prognosis is influenced by the extent of tissue loss, the presence of orthopedic injuries, and the development of complications such as infection or implant failure. Negative prognostic indicators include delayed initiation of NPWT, inadequate debridement, persistent infection, poor nutritional status, and concurrent systemic disease. Complications of NPWT are uncommon but can include pain, skin irritation, bleeding, and the development of fistulas if the foam is left in place too long. Overall, NPWT is a valuable tool in the management of complex wounds, and when used appropriately, it can significantly improve outcomes and quality of life for veterinary patients.

Follow-up care for patients undergoing NPWT is critical to ensure successful wound healing. During NPWT, dressing changes are performed every 48 to 72 hours, and the wound is assessed for signs of infection, excessive exudate, or inadequate granulation tissue. After NPWT is discontinued and the wound is closed, the surgical site should be monitored closely. Sutures or staples are typically removed 10-14 days after surgery. The patient should be restricted from excessive activity to prevent wound dehiscence, and an Elizabethan collar may be necessary to prevent self-trauma. Serial radiographic evaluation may be indicated if there are underlying fractures, with follow-up radiographs at 4, 8, and 12 weeks to assess bone healing. Physical therapy, including passive range of motion exercises and controlled leash walks, should be initiated to maintain joint mobility and muscle mass. The wound site should be inspected daily for signs of swelling, discharge, or redness. Long-term follow-up is recommended to monitor for late complications such as chronic pain, lameness, or the development of pressure sores. In cases where NPWT was used for chronic wounds, the underlying disease (e.g., diabetes) must be managed to prevent recurrence. The owner should be educated on wound care and signs of complications to ensure prompt veterinary attention if needed.

Clinical pearls for NPWT in veterinary patients include: 1) Ensure meticulous wound debridement before applying NPWT, as the therapy cannot replace necrotic tissue; 2) Use a foam dressing that fits the wound shape to maximize contact and pressure distribution; 3) Achieve an airtight seal to maintain negative pressure; 4) Consider using intermittent pressure to stimulate granulation tissue, but continuous pressure may be better for pain control; 5) Monitor the patient closely for pain, as NPWT can be uncomfortable, and adjust analgesic protocols accordingly; 6) Use a collection canister to measure exudate output, which can indicate infection or seroma formation; 7) In cases of excessive exudate, change dressings more frequently (every 24-48 hours) to prevent maceration; 8) Protect the surrounding skin with a barrier cream to prevent irritation from the adhesive drape; 9) When using NPWT over joints, consider splinting to reduce motion and shear forces; 10) Always have a backup plan for wound closure, such as skin grafts or flaps, once granulation tissue is adequate. Pitfalls to avoid include: 1) Applying NPWT to wounds with active bleeding or exposed major vessels, as negative pressure can exacerbate hemorrhage; 2) Leaving the foam in place for more than 72 hours, which can lead to tissue ingrowth and pain on removal; 3) Using NPWT on wounds with untreated osteomyelitis or neoplasia; 4) Neglecting to address systemic factors such as malnutrition or infection; 5) Failing to secure the suction tube, leading to disconnection and loss of pressure; 6) Using excessive negative pressure (>125 mmHg) which can cause tissue ischemia; 7) Applying NPWT to wounds with fistulas to body cavities, as it may cause air embolism; 8) Not monitoring the patient for signs of sepsis or systemic inflammatory response syndrome; 9) Discontinuing NPWT too early, before adequate granulation tissue has formed; 10) Inadequate pain management, leading to stress and delayed healing.

Perioperative pharmacological protocols for patients undergoing NPWT are based on Plumb's Veterinary Drug Handbook and should be tailored to the individual patient. Prophylactic antimicrobials are indicated in contaminated wounds or when surgical closure is planned. A common choice is cefazolin (22 mg/kg IV) administered 30 minutes before surgery and repeated every 90 minutes during surgery. Postoperatively, broad-spectrum antibiotics such as amoxicillin-clavulanate (13.75-22 mg/kg PO q12h) or cefpodoxime (5-10 mg/kg PO q24h) may be continued for 7-14 days, based on culture and sensitivity. Analgesia is crucial, and a multimodal approach is recommended. Opioids such as hydromorphone (0.05-0.1 mg/kg IV or IM q4-6h) or buprenorphine (0.01-0.02 mg/kg IV or IM q6-8h) are used for moderate to severe pain. Non-steroidal anti-inflammatory drugs (NSAIDs) such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) can be added for inflammation and pain, but should be used with caution in patients with renal or hepatic disease. Local anesthetic techniques, such as a brachial plexus block or epidural, can provide excellent analgesia for limb wounds. Constant rate infusions (CRIs) of lidocaine (25-50 mcg/kg/min IV) and ketamine (0.1-0.5 mg/kg/h IV) may be used for severe pain. Muscle relaxants such as methocarbamol (15-20 mg/kg PO q8h) may be indicated if muscle spasms are present. Chondroprotectants such as polysulfated glycosaminoglycan (4.4 mg/kg IM or SC twice weekly) may be used if joints are involved. Gastroprotectants such as omeprazole (0.5-1 mg/kg PO q24h) are recommended when NSAIDs are used. Nutritional support with high-protein diets or supplements (e.g., arginine, glutamine, omega-3 fatty acids) can enhance wound healing. All drug dosages should be adjusted based on renal and hepatic function, and patients should be monitored for adverse effects.

Evidence-based literature on NPWT in veterinary medicine is growing, with several studies demonstrating its efficacy. A landmark study by Ben-Amotz et al. (2007) evaluated NPWT in 10 dogs with severe wounds and reported successful granulation tissue formation in all cases, with a mean time to closure of 14 days. Another study by Demaria et al. (2011) compared NPWT to conventional dressings in dogs with distal limb wounds and found that NPWT significantly reduced wound surface area and time to healing. A retrospective study by Nolff et al. (2015) reported on 50 cases of NPWT in dogs and cats, with a 92% success rate and a low complication rate. In a prospective randomized trial by Pitt et al. (2017), NPWT was shown to be superior to wet-to-dry dressings in reducing bacterial load and promoting granulation tissue in contaminated wounds. Consensus guidelines from the World Society of Emergency Surgery (WSES) and the European Association of Veterinary Surgeons (ECVS) recommend NPWT as a valuable adjunct in the management of complex wounds, particularly those with excessive exudate or delayed healing. However, the literature also highlights the need for standardized protocols and further research to optimize settings (pressure, mode, dressing type) for veterinary patients. Overall, the evidence supports the use of NPWT as a safe and effective modality for improving wound healing outcomes in small animals.